Bio-Rad Laboratories (BIO) Total Debt (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Total Debt for 18 consecutive years, with $1.6 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Debt rose 33.43% year-over-year to $1.6 billion in Q2 2026; TTM through Jun 2026 was $1.6 billion, a 33.43% increase from a year earlier, with the FY2025 full-year figure at $1.2 billion, changed 0.22% from the prior year.
• Total Debt was $1.6 billion for Q2 2026 at Bio-Rad Laboratories, roughly flat from $1.6 billion in the prior quarter.
• Over five years, Total Debt peaked at $1.6 billion in Q2 2026 and troughed at $1.2 billion in Q1 2022.
• A 5-year average of $1.2 billion and a median of $1.2 billion in 2024 frame the typical range for Total Debt.
• Across the five-year window, Total Debt soared 10789.58% in 2022 and gained 0.11% in 2023, its largest moves.
• Over 5 years, Total Debt stood at $1.2 billion in 2022, then increased by 0.12% to $1.2 billion in 2023, then advanced by 0.17% to $1.2 billion in 2024, then gained by 0.22% to $1.2 billion in 2025, then jumped by 33.22% to $1.6 billion in 2026.
• The last three Total Debt figures came in at $1.6 billion (Q2 2026), $1.6 billion (Q1 2026), and $1.2 billion (Q4 2025), per Business Quant data.